You are now leaving the Lilly Medical Education website
The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to Lilly Medical Education.
Mantle Cell Lymphoma (MCL) Overview
Explore our resources for healthcare providers on mantle cell lymphoma (MCL).
Date of Last Review: February 26, 2024
Document Number: VV-MED-152348
Related Resources
In this slide deck, health care professionals will gain deeper knowledge of Mantle Cell Lymphoma (MCL) including epidemiology, pathophysiology, clinical presentation & evaluation, and treatment.
This infographic is intended to educate Health Care Providers on MCL prognostic factors and biomarker testing.
This slide deck is intended to educate Health Care Providers on the pathophysiology and etiology of MCL and describe the importance of prognostic factors and biomarker testing in MCL.
Despite advances, patients with relapsed/refractory MCL experience limited long-term benefit. Health care professionals will learn about the unmet need and poor prognosis in this space.
This implementation guide will assist walking the HCP through the MCL patient journey map.
This roadmap is an educational tool about treatment pathways for patients diagnosed with MCL. It is designed to be used in discussions between healthcare professionals (HCPs) and their patients.
Please rate your satisfaction with the content on the following statements:
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied